FDA-approved
Digestive & weight
Plecanatide
Evidence
FDA approved
Class
Guanylate cyclase-C agonist
KEY TAKEAWAY
Plecanatide is a 16-amino-acid peptide that closely resembles uroguanylin, a natural hormone of the gut. It is sold as Trulance. The FDA approved plecanatide (Trulance) in 2017 for chronic idiopathic constipation and in 2018 for irritable bowel syndrome with constipation.
Written by the Veylo editorial team · Updated
November 2026
What it is
Guanylate cyclase-C agonist
Approved for
Chronic constipation and irritable bowel syndrome with constipation
Key fact
The FDA approved plecanatide (Trulance) in 2017 for chronic idiopathic constipation and in 2018 for irritable bowel syndrome with constipation.
Route
Oral tablet once a day
Evidence strength
FDA approved
Plecanatide is a 16-amino-acid peptide that closely resembles uroguanylin, a natural hormone of the gut. It is sold as Trulance.
It activates guanylate cyclase-C on the intestinal lining, which increases fluid and movement in the bowel.
The FDA approved plecanatide (Trulance) in 2017 for chronic idiopathic constipation and in 2018 for irritable bowel syndrome with constipation.
Chronic constipation and irritable bowel syndrome with constipation.
Diarrhea is the most common side effect. The label carries a boxed warning against use in young children because of dehydration risk.
U.S. FDA prescribing information for Plecanatide. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.